High-Dividend Covered Call and China Biotech ETFs Lead KOSPI Losses, Up 15.5% and 14% in Past Month

According to KOSCOM ETF CHECK, high-dividend covered call and China biotech-focused ETFs outperformed the broader market over the past month ending July 21, as investors shifted away from underperforming semiconductor stocks.

RISE 200 High Dividend Covered Call ATM gained 15.51% and TIGER China Biotech SOLACTIVE rose 14.02% during the period, ranking second and third respectively. TIGER Global AI Cybersecurity led with 18.15%. Covered call strategies, which sell call options on dividend-paying stocks to generate premium income, provided downside protection as the KOSPI fell. Chinese biotech firms gained attention following major global partnerships, including Innovent Biologics' $10.5 billion deal with Pfizer in May and Dizal Pharmaceuticals' $1.5 billion agreement with AstraZeneca.